Von hippel-lindau disease and erythrocytosis

Luciana Teofili, Maurizio Martini, Luigi Maria Larocca, Sara Capodimonti, Tonia Cenci, Maria Bianchi, Marina Murdolo, Giuseppe Leone, Mg Iachininoto, Er Nuzzolo

Research output: Contribution to journalArticle

16 Citations (Scopus)


The increased transcription of HIF target genes plays a key role in the promotion of the angiogenic phenotype that is a characteristic of VHL disease–related tumors. The deregulated oxygen sensing pathway is responsible for the clinical picture that is characteristic of congenital polycythemia as a result of the homozygous VHLR200W mutation, which is characterized by erythrocytosis, pulmonary hypertension, and vertebral hemangiomas. We describe for the first time the contemporary presence in a single patient of these two different clinical phenotypes engendered by germline VHL mutations.
Original languageEnglish
Pages (from-to)e137-e137-9
JournalJournal of Clinical Oncology
Publication statusPublished - 2012


  • Adrenal Gland Neoplasms
  • Adult
  • Aspirin
  • Biological Markers
  • Biopsy
  • DNA Mutational Analysis
  • Erythropoietin
  • Genetic Predisposition to Disease
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Mutation
  • Pedigree
  • Phenotype
  • Pheochromocytoma
  • Phlebotomy
  • Polycythemia
  • Treatment Outcome
  • Von Hippel-Lindau Tumor Suppressor Protein
  • von Hippel-Lindau Disease

Fingerprint Dive into the research topics of 'Von hippel-lindau disease and erythrocytosis'. Together they form a unique fingerprint.

Cite this